Following on from Dr.DermMIA — and this may be the naive question:
What actually distinguishes 503A from 503B, in terms of what each may make and from what starting material?
BenResearch_OR said:The bulks-list asymmetry was the piece I had missed entirely.
Filing a mild objection. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit. The counter-case has not been addressed. Somebody upthread described the situation that does not fit, and the thread moved on rather than engaging with it, which is the failure mode this board is supposed to avoid.
Ask again with the specifics and you will get a better answer than this one.
BenResearch_OR said:The bulks-list asymmetry was the piece I had missed entirely.
True, and it depends on a baseline nobody has stated. Without knowing where someone started, the same number can be an excellent result or a disappointing one.
Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.
Verify Your PeptidesEst. 1998. The synthesis house behind the vials you send for testing. ISO 9001 and cGMP certified, 1,500+ staff, batch-specific COA with every order.
Browse GL BiochemBenResearch_OR said:The bulks-list asymmetry was the piece I had missed entirely.
Thank you for spelling out the reasoning rather than just the conclusion. Sending this to two other people who asked me the same thing last week.
Adding the clinical framing, because it changes how the question reads. The mechanism and the magnitude are separate questions. Agreeing that something happens says nothing about whether it happens enough to act on.